The desmopressin test as a predictive factor of outcome after pituitary surgery for Cushing's disease.

@article{Valro2004TheDT,
  title={The desmopressin test as a predictive factor of outcome after pituitary surgery for Cushing's disease.},
  author={Ren{\'e} Val{\'e}ro and Sophie Vallette-Kasic and Bernard Conte-Devolx and Philippe Jaquet and Thierry Brue},
  journal={European journal of endocrinology},
  year={2004},
  volume={151 6},
  pages={727-33}
}
OBJECTIVE Taking advantage of the over-expression of V3 receptors in adenomatous corticotroph cells, we evaluated the response to the vasopressin agonist desmopressin in 22 patients operated on for Cushing's disease, with a mean follow-up of 4.5 years. SUBJECTS AND METHODS Twenty-two patients (17 women) operated on for Cushing's disease with a follow-up >2 years (median, 48; range, 24-141 months) underwent one desmopressin test (10 microg i.v. bolus) 3-6 months postoperatively. Twelve were in… CONTINUE READING